Study to Determine the Safety and Tolerability of TG-C in Subjects With Back Pain Due to Degenerative Disc Disease
Clinical trial NCT06144970 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06144970
- Sponsor
- Kolon TissueGene, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2027-01-19
- Primary completion
- 2028-07-28
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.